Looking for online definition of dyslipidemia or what dyslipidemia stands for? dyslipidemia is listed in the World's most authoritative dictionary of abbreviations and acronyms
it is extremely common in modern society. Dyslipidemia is when the blood test indicates high total cholesterol, high LDLbad cholesterol, low HDLgood cholesterol, or high levels of triglycerides. A broader definition could include elevated levels of other fatty materials or even too-low levels choles...
Obesity affects metabolism of lipids and glucose, r... Grundy,M Scott - 《Endocrinol Metab Clin North Am》 被引量: 173发表: 2004年 The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? The metabolic syndrome ...
dyslipidemia, type 2 diabetes mellitus, cardiovascular disease (CVD), and several cancers [4,5,6], all of which render obesity to be consistently associated with increased mortality [7,8]. Therefore, there is inevitable need for measures to manage obesity and its related disorders....
Accordingly, the first key take-away of this review is to incorporate change from the creation of the treatment plan for the patient: looking beyond hyperglycemia. Large-scale studies in type 2 diabetes patients have proven to be a treasure-trove for insights into the nature and management of ...
the disease. Decades of data have elucidated the full range of hyperglycemia-related conditions and long-term complications. The continuum of related conditions spans obvious conditions, including obesity and metabolic syndrome, prediabetes, type 2 diabetes, hypertension, and dyslipidemia, and includes ...
Non-alcoholic fatty liver disease (NAFLD) is a definition of a prevalent condition that has been given a name describing what the disease is not, mainly due to gaps in the physiopathological understanding of NAFLD when the name was given to it. NAFLD still remains an unmet clinical need to...
An outstanding challenge is to identify which NAFLD patients have NASH, and so are at risk of cirrhosis. Another challenge arises from the association of NAFLD (and particularly NASH) with insulin resistance, impaired glucose tolerance or type 2 diabetes, atherogenic dyslipidemia, and metabolic ...
Cardiometabolic diseases (CMD), including type 2 diabetes (T2D) and cardiovascular disease (CVD), and their associated factors, such as hypertension, dyslipidemia, insulin resistance and obesity are among the leading causes of morbidity and mortality in both sexes [1]. However, men and women exper...
The planning of a clinical trial depends on the question that the investigator is addressing. The general objective is usually obvious, but the specific question to be answered by the trial is often not stated well. Stating the question clearly and in ad